---
title: "EraCal 治療公司與諾和諾德公司合作開發和商業化 EraCal 治療肥胖的口服小分子計劃，獲得高達 2.35 億歐元的預付款、開發和商業里程碑"
description: "Https://www.eracal.ch/_files/ugd/b8426d_f96f5439a98b4f2db3e0fa5f5ee1c570."
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/106555710.md"
published_at: "2024-01-23T16:59:32.000Z"
---

# EraCal 治療公司與諾和諾德公司合作開發和商業化 EraCal 治療肥胖的口服小分子計劃，獲得高達 2.35 億歐元的預付款、開發和商業里程碑

> Https://www.eracal.ch/_files/ugd/b8426d_f96f5439a98b4f2db3e0fa5f5ee1c570.

Https://www.eracal.ch/\_files/ugd/b8426d\_f96f5439a98b4f2db3e0fa5f5ee1c570.pdf

### Related Stocks

- [08426.HK - 雅居投資控股](https://longbridge.com/zh-HK/quote/08426.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| We Don’t Predict. We Position: How Jon Turned $4K of Risk Into a $30K Return | We Don’t Predict. We Position: How Jon Turned $4K of Risk Into a $30K Return | [Link](https://longbridge.com/zh-HK/news/276067278.md) |
| Tencent has a key advantage over other Chinese AI stocks: here's what it is | Tencent has a unique "trust advantage" in the competitive Chinese AI sector, according to Rupert Mitchell, a market obse | [Link](https://longbridge.com/zh-HK/news/276073565.md) |
| SADAFCO H2 Dividend Per Share Sar 8 | SAUDIA DAIRY & FOODSTUFF :SADAFCO- H2 DIVIDEND PER SHARE SAR 8 | [Link](https://longbridge.com/zh-HK/news/276059054.md) |
| Al Waha Capital FY Dividend 10 Fils /Share | AL WAHA CAPITAL :FY DIVIDEND 10 FILS PER SHARE | [Link](https://longbridge.com/zh-HK/news/276031213.md) |
| REG - AIM - AIM Notice - 16/02/2026 | The London Stock Exchange has admitted several securities to trading on AIM as of February 16, 2026. The companies liste | [Link](https://longbridge.com/zh-HK/news/276041707.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。